By Marion Renault and Marshall Ritzel

Almost six months after a rare face and hands transplant, Joe DiMeo is relearning how to smile, blink, pinch and squeeze.

The 22-year-old New Jersey resident had the operation last August, two years after being badly burned in a car crash.

“I knew it would be baby steps all the way,” DiMeo told The Associated Press. “You’ve got to have a lot of motivation, a lot of patience. And you’ve got to stay strong through everything.”

Experts say it appears the surgery at NYU Langone Health was a success, but warn it’ll take some time to say for sure.

Worldwide, surgeons have completed at least 18 face transplants and 35 hand transplants, according to the United Network for Organ Sharing, or UNOS, which oversees the U.S. transplant system.

But simultaneous face and double hand transplants are extremely rare and have only been tried twice before. The first attempt was in 2009 on a patient in Paris who died about a month later from complications. Two years later, Boston doctors tried it again on a woman who was mauled by a chimpanzee, but ultimately had to remove the transplanted hands days later.

“The fact they could pull it off is phenomenal,” said Dr. Bohdan Pomahac, a surgeon at Boston’s Brigham and Women’s Hospital who led the second such attempt. “I know firsthand it’s incredibly complicated. It’s a tremendous success.”

DiMeo will be on lifelong medications to avoid rejecting the transplants, as well as continued rehabilitation to gain sensation and function in his new face and hands.

In 2018, DiMeo fell asleep at the wheel, he said, after working a night shift as a product tester for a drug company. The car hit a curb and utility pole, flipped over, and burst into flames. Another driver who saw the accident pulled over to rescue DiMeo.

Afterward, he spent months in a medically induced coma and underwent 20 reconstructive surgeries and multiple skin grafts to treat his extensive third-degree burns.

Once it became clear conventional surgeries could not help him regain full vision or use of his hands, DiMeo’s medical team began preparing for the risky transplant in early 2019.

“Within the world of transplantation, they’re probably the most unusual,” said Dr. David Klassen, UNOS chief medical officer.

Almost immediately, the NYU team encountered challenges including finding a donor.

Doctors estimated he only had a 6% chance of finding a match compatible with his immune system. They also wanted to find someone with the same gender, skin tone and hand dominance.

Then during the search for a donor, the pandemic hit and organ donations plummeted. During New York City’s surge, members of the transplant unit were reassigned to work in COVID-19 wards.

In early August, the team finally identified a donor in Delaware and completed the 23-hour procedure a few days later.

They amputated both of DiMeo’s hands, replacing them mid-forearm and connecting nerves, blood vessels and 21 tendons with hair-thin sutures. They also transplanted a full face, including the forehead, eyebrows, nose, eyelids, lips, both ears and underlying facial bones.

“The possibility of us being successful based on the track record looked slim,” said Dr. Eduardo Rodriguez, who led the medical team of more than 140 people. “It’s not that someone has done this many times before and we have a kind of a schedule, a recipe to follow.”

So far, DiMeo has not shown any signs of rejecting his new face or hands, said Rodriguez, who revealed details of the transplant Wednesday.

Since leaving the hospital in November, DiMeo has been in intensive rehabilitation, devoting hours daily to physical, occupational and speech therapy.

“Rehab was pretty intense,” DiMeo said, and involves a lot of “retraining yourself to do stuff on your own again.”

During a recent session, he practiced raising his eyebrows, opening and closing his eyes, puckering his mouth, giving a thumbs up and whistling. DiMeo can feel his new forehead and hands get cold, and often reaches up to push his long hair off of his face.

DiMeo, who lives with his parents, can now dress and feed himself. He shoots pool and plays with his dog Buster. Once an avid gym-goer, DiMeo is also working out again — benching 50 pounds and practicing his golf swing.

“You got a new chance at life. You really can’t give up," he said.

As with any transplant, the danger of rejection is highest early on, but lasts indefinitely. The medications he takes also leave him vulnerable, for the rest of his life, to infections.

“You’re never free from that risk,” Klassen said. “Transplantation for any patient is a process that plays out over a long period of time.”

Still, Rodriguez said he’s amazed to see that DiMeo has been able to master skills like zipping up his jacket and putting on his shoes.

“It’s very gratifying to all of us,” Rodriguez said. “There’s a tremendous sense of pride.”

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
New BA.2 Variant Predicted to Boost Covid Cases in U.S.
A subvariant of the omicron COVID-19 variant called BA.2 is causing an outbreak overseas. Now, some health experts worry it could also lead to an increase in COVID-19 cases in the U.S. Dr. Amesh Adalja, infectious disease specialist and senior scholar at Johns Hopkins Center for Health Security, joins Cheddar News to discuss.
Green Battery Materials Maker Nouveau Monde Graphite Aims to Power Energy Revolution
Nouveau Monde Graphite says it wants to power the sustainable energy revolution. The Canadian company is developing carbon-neutral battery materials to serve the growing EV and cleantech markets and is doing so via a mining and manufacturing operation in Quebec. Eric Desaulniers, founder, president & CEO of Nouveau Monde Graphite, joins Cheddar News' Closing Bell to discuss.
There's A New Subvariant. How Concerned Should We Be?
Health experts are warning an even more contagious subvariant of Omicron, known as BA.2, could soon lead to another surge in Covid cases here in the U.S. The variant has already driven cases to skyrocket in China and Europe, which has historically served as a preview to the pattern the U.S. has seen throughout the pandemic. This comes at a time when protection from booster shots is waning for most people who got them. Dr. Jen Caudle, Family Physician & Associate Professor at Rowan University, explains what we can do to protect ourselves against the new variant and how we should act as warnings of another surge rise.
Cresco Labs to Become the Largest U.S. Cannabis Company by Sales With Columbia Care Acquisition
Cannabis producer Cresco Labs is acquiring rival Columbia Care in a $2 billion all-stock deal, creating the largest U.S. cannabis company by sales. The deal, which is expected to close in the fourth quarter of 2022, is one of the biggest in the industry's history and would make Cresco the dominant player in a market projected to reach $46 billion in revenue by 2026. Charlie Bachtell, CEO of Cresco Labs, joins Cheddar News' Closing Bell to discuss.
Breaking Down Moderna Seeking COVID Vaccine Approval for Kids Under 6
Moderna announced it's seeking emergency use approval for its COVID-19 vaccine from the FDA for children under 6 years old. A former FDA associate commissioner and the president and co-founder of the Center for Medicine in the Public Interest (CMPI) Peter Pitts joined Cheddar News to talk about the timeline, benefits, and risks that come with the approval of the vaccine. "We want to protect their parents and their grandparents and their caregivers and their daycare providers, so it's all about protecting not just the kids but all around the people that are surrounding those kids," he said.
Load More